Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas

被引:54
作者
Suehiro, Y
Sakamoto, M
Umayahara, K
Iwabuchi, H
Sakamoto, H
Tanaka, N
Takeshima, N
Yamauchi, K
Hasumi, K
Akiya, T
Sakunaga, H
Muroya, T
Numa, F
Kato, H
Tenjin, Y
Sugishita, T
机构
[1] Kyoundo Hosp, Sasaki Inst, Dept Gynecol, Tokyo, Japan
[2] Olympus Opt Co Ltd, Chromosome Res Ctr, Hachioji, Tokyo, Japan
[3] Canc Inst Hosp, Dept Gynecol, Tokyo, Japan
[4] Yamaguchi Univ, Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan
关键词
comparative genomic hybridization; ovarian cancer; clear cell adenocarcinoma; copy number abnormalities;
D O I
10.1159/000012137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic abnormalities were detected by comparative genomic hybridization (CGH) in 12 ovarian clear cell adenocarcinomas. DNA sequence copy number abnormalities (CNAs) occurring in more than 20% of the cancers included increased copy numbers of 8q11-q13, 8q21-q22, 8q23, 8q24-qter, 17q25-qter, 20q13-qter and 21q22-qter and reduced copy numbers of 19p. Increases in copy numbers of 8q11-q13, 8q21-q22, 8q23 and 8q24-qter occurred more frequently in disease-free patients than in recurrent/non-surviving patients (p < 0.05). However, increases in copy numbers of 17q25-qter and 20q13-qter occurred more frequently in recurrent/non-surviving patients than in disease-free patients (p < 0.05). Furthermore, increases in copy numbers of 17q25-qter and 20q13-qter occurred together (p < 0.05). Additionally, there were negative correlations between increases in copy numbers of 8q21-q22 and 17q25-qter, and between 8q21-q22 and 20q13-qter (p < 0.05). It appears that ovarian clear cell adenocarcinomas can be classified into two subtypes, one being cancer with an increase in copy numbers of 8q and the other being cancer with increases in copy numbers of 17q25-qter and 20q13-qter. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 26 条
[1]  
AMFO K, 1995, ONCOGENE, V11, P351
[2]   C-MYC AMPLIFICATION IN OVARIAN-CANCER [J].
BAKER, VV ;
BORST, MP ;
DIXON, D ;
HATCH, KD ;
SHINGLETON, HM ;
MILLER, D .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :340-342
[3]   Clinical characteristics of clear cell carcinoma of the ovary [J].
Behbakht, K ;
Randall, TC ;
Benjamin, I ;
Morgan, MA ;
King, S ;
Rubin, SC .
GYNECOLOGIC ONCOLOGY, 1998, 70 (02) :255-258
[4]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[5]  
BERNS EMJJ, 1992, CANCER RES, V52, P1107
[6]   ONCOGENESIS IN OVARIAN-CANCER [J].
BORRESEN, AL .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 :25-30
[7]  
Cher ML, 1996, CANCER RES, V56, P3091
[8]  
Diebold J, 1996, VIRCHOWS ARCH, V429, P221
[9]   ALLELOTYPE OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - FRACTIONAL ALLELE LOSS CORRELATES WITH SURVIVAL [J].
FIELD, JK ;
KIARIS, H ;
RISK, JM ;
TSIRIYOTIS, C ;
ADAMSON, R ;
ZOUMPOURLIS, V ;
ROWLEY, H ;
TAYLOR, K ;
WHITTAKER, J ;
HOWARD, P ;
BEIRNE, JC ;
GOSNEY, JR ;
WOOLGAR, J ;
VAUGHAN, ED ;
SPANDIDOS, DA ;
JONES, AS .
BRITISH JOURNAL OF CANCER, 1995, 72 (05) :1180-1188
[10]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663